NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 5 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $893 | -44.1% | 4,700 | 0.0% | 0.00% | – |
| Q1 2023 | $1,598 | +5.1% | 4,700 | 0.0% | 0.00% | – |
| Q4 2022 | $1,520 | -24.0% | 4,700 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 4,700 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -71.4% | 4,700 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $7,000 | -58.8% | 4,700 | 0.0% | 0.00% | -66.7% |
| Q2 2020 | $17,000 | +54.5% | 4,700 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $11,000 | – | 4,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 277,177 | $915,000 | 0.11% |
| WEBSTER BANK, N. A. | 50,000 | $165,000 | 0.02% |
| Brown Advisory Securities, LLC | 28,000 | $92,000 | 0.02% |
| SIMPLEX TRADING, LLC | 50,804 | $167,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $83,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 89,372 | $295,000 | 0.00% |
| Squarepoint Ops LLC | 10,194 | $34,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,851 | $6,000 | 0.00% |
| WOLVERINE TRADING, LLC | 58,500 | $193,000 | 0.00% |
| WOLVERINE TRADING, LLC | 61,690 | $204,000 | 0.00% |